Cryofocus Medtech to Review 1H26 Interim Results and Potential Dividend on 28 August 2026

Bulletin Express

Aug 18

Cryofocus Medtech (Shanghai) Co., Ltd. has scheduled a board meeting for 28 August 2026. Directors will evaluate and approve the Group’s interim financial results for the six months ended 30 June 2026 and deliberate on a possible interim dividend declaration.

The board currently consists of Executive Directors LI Kejian (Chairman), ZHU Jun and LIU Wei; Non-executive Directors LV Shiwen and ZHAO Chunsheng; and Independent Non-executive Directors GAO Dayong, LIANG Hsien Tse Joseph, QIN Zheng and HU Henan.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1142041199"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1142041199\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1142041199?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-18 16:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1142041199","market":"us","top_or_hot":-1,"title":"Cryofocus Medtech to Review 1H26 Interim Results and Potential Dividend on 28 August 2026","media":"Bulletin Express","content":"<p>Cryofocus Medtech (Shanghai) Co., Ltd. has scheduled a board meeting for 28 August 2026. Directors will evaluate and approve the Group’s interim financial results for the six months ended 30 June 2026 and deliberate on a possible interim dividend declaration.</p>\n<p>The board currently consists of Executive Directors LI Kejian (Chairman), ZHU Jun and LIU Wei; Non-executive Directors LV Shiwen and ZHAO Chunsheng; and Independent Non-executive Directors GAO Dayong, LIANG Hsien Tse Joseph, QIN Zheng and HU Henan.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cryofocus Medtech to Review 1H26 Interim Results and Potential Dividend on 28 August 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCryofocus Medtech to Review 1H26 Interim Results and Potential Dividend on 28 August 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-18 16:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Cryofocus Medtech (Shanghai) Co., Ltd. has scheduled a board meeting for 28 August 2026. Directors will evaluate and approve the Group’s interim financial results for the six months ended 30 June 2026 and deliberate on a possible interim dividend declaration.</p>\n<p>The board currently consists of Executive Directors LI Kejian (Chairman), ZHU Jun and LIU Wei; Non-executive Directors LV Shiwen and ZHAO Chunsheng; and Independent Non-executive Directors GAO Dayong, LIANG Hsien Tse Joseph, QIN Zheng and HU Henan.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06922","symbol_name":"康沣生物-B","start_time":0,"source_url":"","article_id":"1142041199","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1142041199","pubTimestamp":1787042873,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Cryofocus Medtech (Shanghai) Co., Ltd. has scheduled a board meeting for 28 August 2026. Directors will evaluate and approve the Group’s interim financial results for the six months ended 30 June...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06922":"康沣生物-B"},"translate_title":"Cryofocus Medtech 将于 2026 年 8 月 28 日审查 26 年上半年中期业绩和潜在股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06922":1},"content_text":"Cryofocus Medtech (Shanghai) Co., Ltd. has scheduled a board meeting for 28 August 2026. Directors will evaluate and approve the Group’s interim financial results for the six months ended 30 June 2026 and deliberate on a possible interim dividend declaration.\nThe board currently consists of Executive Directors LI Kejian (Chairman), ZHU Jun and LIU Wei; Non-executive Directors LV Shiwen and ZHAO Chunsheng; and Independent Non-executive Directors GAO Dayong, LIANG Hsien Tse Joseph, QIN Zheng and HU Henan.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}